IP Library Granted Patent US 10,317,321
Granted Patent B2
US 10,317,321 · App. 15/229,545 · Granted Jun 11, 2019

Protein retention expansion microscopy

Inventors: Paul Warren Tillberg (Cambridge, MA); Fei Chen (Cambridge, MA); Edward Stuart Boyden (Chestnut Hill, MA); Chih-Chieh Yu (Cambridge, MA)
Assignee: Massachusetts Institute of Technology
G01N1/30G01N1/36G01N33/582G01N33/6803G01N2001/302G01N2001/307G01N2333/95
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,317,321
App. No.
15/229,545
Granted
Jun 11, 2019
Kind
B2
Abstract

The invention provides a method termed protein retention ExM (proExM), in which proteins, rather than labels, are anchored to the swellable gel, using a cross-linking molecule. This proExM strategy can be used to perform nanoscale imaging of immunostained cells and tissues as well as samples expressing various FPs as fluorescent signals from genetically encoded fluorescent proteins and/or conventional fluorescently labeled secondary antibodies and streptavidin that are directly anchored to the gel are preserved even when subjected to the nonspecific proteolytic digestion.

Claims (38)

1. A method for the retention and imaging of proteins of a sample of interest comprising the steps of:

(a) conjugating proteins within the sample with a bifunctional crosslinker, wherein the bifunctional crosslinker comprises a protein-reactive chemical group and a gel-reactive chemical group;

(b) embedding the sample in a swellable material wherein proteins within the sample are anchored to the swellable material;

(c) subjecting the sample to digestion;

(d) swelling the swellable material to form an expanded sample;

(e) staining the sample either before or after steps (a) (b), (c), or (d); and

(f) imaging the expanded sample.

2. The method according to claim 1 , wherein the bifunctional crosslinker is succinimidyl ester of 6-((acryloyl)amino)hexanoic acid (AcX).

3. The method according to claim 1 , wherein the digestion is a physical, chemical, or enzymatic disruption of the sample.

4. The method according to claim 1 , wherein the sample is subjected to antibody staining.

5. The method according to claim 4 , wherein the sample is stained with one or more antibodies prior to treatment with conjugation with the bifunctional crosslinker.

6. The method according to claim 4 , wherein the sample is stained with one or more antibodies after the sample is in the expanded state, and the digestion preserves protein antigenicity.

7. The method according to claim 1 , wherein the sample expresses one or more fluorescent proteins.

8. The method according to claim 7 , wherein the one or more fluorescent proteins are anchored to the swellable material.

9. The method according to claim 1 , wherein the sample is expanded isotropically by adding water to swell the swellable material.

10. The method according to claim 3 , wherein the digestion step comprises treating the sample with LysC protease, autoclaving, or proteinase K.

11. The method according to claim 3 , wherein the disruption method is an enzymatic digestion.

12. The method according to claim 1 , wherein embedding the biological sample in a swellable material comprises permeating the biological sample with a composition comprising precursors of a swellable polymer and forming a swellable polymer in situ.

13. The method according to claim 1 , wherein the at least one protein is anchored to the swellable material.

14. A method for the retention and imaging of proteins of a sample of interest comprising the steps of:

(a) conjugating proteins within the sample with a bifunctional crosslinker, wherein the bifunctional crosslinker comprises a protein-reactive chemical group and a gel-reactive chemical group;

(b) embedding the sample in a swellable material wherein proteins within the sample are anchored to the swellable material;

(c) swelling the swellable material to form an expanded sample;

(d) staining the sample either before or after steps (a) (b), or (c); and

(e) imaging the expanded sample.

15. The method according to claim 14 , wherein the bifunctional crosslinker is succinimidyl ester of 6-((acryloyl)amino)hexanoic acid (AcX).

16. The method according to claim 14 , wherein the method further comprises subjecting the sample to digestion.

17. The method according to claim 16 , wherein the digestion is a physical, chemical, or enzymatic disruption of the sample.

18. The method according to claim 16 , wherein the digestion preserves protein antigenicity.

19. The method according to claim 14 , wherein the sample is subjected to antibody staining.

20. The method according to claim 19 , wherein the sample is stained with one or more antibodies prior to treatment with conjugation with the bifunctional crosslinker.

21. The method according to claim 19 , wherein the sample is stained with one or more antibodies after the sample is in the expanded state.

22. The method according to claim 14 , wherein the sample expresses one or more fluorescent proteins.

23. The method according to claim 22 , wherein the one or more fluorescent proteins are anchored to the swellable material.

24. The method according to claim 14 , wherein the sample is expanded isotropically by adding water to swell the swellable material.

25. The method according to claim 17 , wherein the digestion step comprises treating the sample with LysC protease, autoclaving, or proteinase K.

26. The method according to claim 17 , wherein the disruption method is an enzymatic digestion.

27. The method according to claim 1 , wherein embedding the biological sample in a swellable material comprises permeating the biological sample with a composition comprising precursors of a swellable polymer and forming a swellable polymer in situ.

Assignments (2)
CONFIRMATORY LICENSE Recorded Apr 27, 2017
From: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 042348/0247 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 3, 2016
From: TILLBERG, PAUL WARREN; CHEN, FEI; BOYDEN, EDWARD STUART; YU, CHIH-CHIEH
To: MASSACHUSETTS INSTITUTE OF TECHNOLOGY
Reel/Frame 039919/0166 →
Continuity (2)
Provisional Application 62202423 · Aug 7, 2015
Related Publication 20170089811A1 · Mar 30, 2017
Cited By (48)
US 12,188,085 US 12,188,087 US 12,188,855 US 12,203,136 US 12,209,273 US 12,215,379 US 12,227,796 US 12,233,184 US 12,234,507 US 12,258,454 US 12,258,624 US 12,264,358 US 12,265,004 US 12,270,071 US 12,270,074 US 12,275,984 US 12,297,499 US 12,319,956 US 12,325,877 US 12,331,347 US 12,360,105 US 12,365,944 US 12,391,984 US 12,400,733 US 12,405,193 US 12,435,364 US 12,460,251 US 12,467,086 US 12,474,241 US 12,497,653 US 12,509,717 US 12,516,369 US 12,529,096 US 12,553,079 US 12,559,790 US 12,559,791 US 12,565,671 US 12,578,320 US 12,618,099 US 12,662,699 US 12,674,196 US 12,687,494 US 12,692,484 US 12,703,879 US 12,709,771 US 12,716,086 US 12,716,092 US 12,718,518